ANI Pharmaceuticals | ANIP - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 33.67B 140M 2026-06
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Canopy Growth CAD 529.47M 4.8M 2026-03
Eli Lilly USD 64.67B 9.84B 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Heron Therapeutics USD 229.84M 861K 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Omeros USD 69.65M 26.53M 2025-06
Perrigo USD 2.45B 260.7M 2026-06
Sun Pharmaceuticals INR 638.6B 37.24B 2026-03
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06